Assessing and accelerating new product introductions in a pharmaceutical plant

Abstract

A multi-period, continuous-time, mixed-integer linear programming model that addresses product introduction issues in pharmaceutical plants using multiple parallel production liens in campaign modes was discussed. The aim was to decide the optimal production levels of various intermediates and optimal supply amounts of various Als to maximize the overall gross profit for the plant. The disruptions that occur in the production of existing products when the new products enter the production phase were also analyzed. The time to market and the quick reap of the profits from the new products before their shortened life cycles are the keys to the success of such pharmaceutical companies.